To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Patient Power Michael Simon, M.D., MPH , medical oncologist and co-leader of the Breast Cancer Multidisciplinary Team at Karmanos, contributes to an article about lobular breast cancer. Also known as invasive lobular carcinoma (ILC), the tumor develops in the milk glands and spreads to other parts of the body. Dr. Simon gives insight into risk factors that may increase the chances of developing ILC and how this type of cancer is diagnosed. Read the article here .
The Barbara Ann Karmanos Cancer Institute ’s 11th Annual Pink Out the Park event with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, was a home run in Motor City. As the Tigers battled against the Seattle Mariners on Friday, May 12, 2023, hundreds of breast cancer survivors and their loved ones filled the stands at Comerica Park, decorated in pink to promote breast cancer awareness and support. “It is gratifying to see so much support from the community of sur...
Michael Simon, M.D., MPH , medical oncologist, co-leader of the Breast Cancer Multidisciplinary Team , and member of the Molecular Therapeutics and the Populations Studies and Disparities Research Programs at Karmanos Cancer Institute, recently co-authored a review with colleagues across the country. “A review of research on the intersection between breast cancer and cardiovascular research in Women’s Health Initiative (WHI)” was published in Frontiers in Oncology in March. The researchers focuse...